⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Mitophagy Inducers
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — Identification of mitophagy inducers for Alzheimer’s disease via high-throughput endogenous ATP5B tagging system.: [animal-model] A preclinical study using high-throughput CRISPR endogenous ATP5B tagging identified flupentixol as a mitophagy inducer acting through mitochondrial AMPK recruitment and activation, with reduced pathology and cognitive deficits in an Alzheimer’s disease mouse model; the finding supplies no human efficacy or longevity outcome data. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Identification of mitophagy inducers for Alzheimer's disease via high-throughput endogenous ATP5B tagging system.
14-nov-2026
novelty 3
per-area 3
strengthens